Cerebrovascular carbon dioxide reactivity is intact in chronic kidney disease

Justin D Sprick1, Jeann Sabino-Carvalho2,3, Elsa Mekonnen2,3

  • 1Department of Kinesiology, Health Promotion and Recreation, University of North Texas, Denton, Texas, USA.

Physiological Reports
|April 3, 2024
PubMed

Insights

Chronic kidney disease (CKD) does not impair cerebrovascular carbon dioxide reactivity (CVR). However, CVR was found to be inversely related to estimated glomerular filtration rate (eGFR) in CKD patients, suggesting other stroke risk factors.

Area of Science:

  • Nephrology
  • Neurology
  • Cardiovascular Science

Background:

  • Chronic kidney disease (CKD) is linked to a higher risk of cerebrovascular diseases, such as stroke.
  • Impaired cerebrovascular carbon dioxide reactivity (CVR) is a potential mechanism contributing to this increased risk.
  • Understanding CVR in CKD patients is crucial for identifying stroke risk factors.

Purpose of the Study:

  • To compare CVR between CKD patients (stages III-IV) and a control group matched for hypertension and diabetes.
  • To investigate the relationship between CVR and estimated glomerular filtration rate (eGFR) in CKD patients.

Main Methods:

  • CVR was measured using 5% CO2 inhalation and voluntary hyperventilation.
  • Continuous monitoring of mean arterial pressure, end-tidal carbon dioxide (etCO2), and middle cerebral artery blood velocity (MCAv).
  • CVR quantified as the linear relationship between etCO2 and MCAv.

Main Results:

  • No significant difference in CVR was observed between CKD patients and controls.
  • Hypercapnic CVR: CKD = 1.2 ± 0.9 cm/s/mmHg vs. CON = 1.3 ± 0.8 cm/s/mmHg.
  • Hypocapnic CVR: CKD = 1.3 ± 0.9 cm/s/mmHg vs. CON = 1.5 ± 0.7 cm/s/mmHg.
  • Integrated CVR: CKD = 1.5 ± 1.1 cm/s/mmHg vs. CON = 1.7 ± 0.8 cm/s/mmHg (p ≥ 0.48).
  • A significant inverse relationship was found between CVR and eGFR in CKD patients (R² = 0.37, p = 0.02).

Conclusions:

  • Cerebrovascular carbon dioxide reactivity (CVR) remains intact in patients with chronic kidney disease (CKD).
  • CVR is inversely related to estimated glomerular filtration rate (eGFR) in CKD.
  • These findings suggest that mechanisms other than CVR contribute to the elevated stroke risk in CKD.

Related Concept Videos

Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
428
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
166
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Renal Drug Excretion: Glomerular Filtration01:02

Renal Drug Excretion: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
255
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.0K